TC Medical(SH:600763) Sou Hu Cai Jing·2025-11-27 11:42Core Viewpoint - Tongce Medical (600763) experienced a slight decline in stock price, closing at 41.76 yuan on November 27, 2025, with a trading volume of 41,100 lots and a total transaction amount of 172 million yuan [1]. Group 1: Stock Performance and Trading Data - On November 27, 2025, the stock price decreased by 0.33%, with a net outflow of main funds amounting to 17.31 million yuan, representing 10.08% of the total transaction amount [1][2]. - Retail investors saw a net inflow of 8.92 million yuan, accounting for 5.19% of the total transaction amount, while speculative funds had a net inflow of 0.84 million yuan, making up 4.88% of the total [1][2]. Group 2: Financial Performance and Industry Comparison - For the first three quarters of 2025, Tongce Medical reported a main revenue of 2.29 billion yuan, a year-on-year increase of 2.56%, and a net profit attributable to shareholders of 514 million yuan, up 3.16% year-on-year [3]. - The company's third-quarter revenue was 842 million yuan, reflecting a 2.34% year-on-year increase, with a net profit of 192 million yuan, also up 2.31% year-on-year [3]. - Key financial metrics show that Tongce Medical has a total market value of 18.679 billion yuan, a net asset of 4.703 billion yuan, and a net profit margin of 26.91%, ranking 3rd in the industry [3]. Group 3: Analyst Ratings and Target Price - Over the past 90 days, 10 institutions have rated the stock, with 7 buy ratings and 3 hold ratings, and the average target price set by analysts is 51.78 yuan [4].